2017 Innovation Grants - Professor Brendan Jenkins

Research
New therapeutic tools

This project aims to show the preclinical efficacy of a novel series of immune-based therapies across a range of human pancreatic tumours which have been genetically screened to predict treatment responsiveness. This project also addresses the need to identify new genes that can be the target of novel therapeutic approaches.

Professor Brendan Jenkins Image

Professor Brendan Jenkins, Hudson Institute of Medical Research

Research Reports
Click to download progress reporting on the outcomes of this research.

Progress Report

Final Report